Compared with the global medical device market, the structure of China's medical device market has been optimized in the past three years, but the structure is still seriously unbalanced. In the early Chinese medical device market, low-end products accounted for nearly 70% of the proportion, while high-end products accounted for only about 30%, while the international medical device market accounted for 55% of high-end products and 45% of low-end products. Such as Xinhua Medical, Dean Diagnostics, Lepu Medical, Yuyue Medical, etc. actively explore the high-end market and seek to develop. iiMedia Research analysts believe that high-end, intelligent and family-oriented are the three most significant trends in the development of China's medical device industry due to the impact of artificial intelligence, Internet of Things, 5G and other technologies. In particular, medical big data, high-end medical imaging equipment, home medical equipment, smart portable medical equipment and other fields will be of great concern.
The number of elderly people in China has increased, and the number of sub-healthy people has exceeded 75.0%. People who have health needs are in favor of the development of massage chair market. In 2018, China's massage chair-related enterprises received an investment of 260 million yuan, with an average investment of more than 50 million yuan per massage chair. Specifically to the two major e-commerce sales channels, the average price of massage chairs in Tianmao Mall is 3158.9 yuan per month, while the average price of the top ten items in Jingdong Mall is 6529.8 yuan. In the massage market segment enterprises, Rongtai Health and Ogawa's first major category in 2018 are massage chairs, whose revenue accounts for 83.0% and 42.2% respectively. Under the extensive penetration of massage concept, the sharing massage chair began to appear. At present, the main application scenarios are in cinemas, scenic spots, subway stations, office buildings, etc.
本报告研究涉及企业/品牌包括:Mavidon,Titan Medical,Aspire Capital Fund,CentriMag,汇桥资本集团,联影医疗技术集团,医达极星,大博医疗,安捷伦,润扬医疗器械,迈瑞医疗,乐普医疗,威高医用,华大基因,安图生物,健帆生物,鱼跃医疗,京东方科技,美亚光电,东软集团,祥生医疗,硕世生物,佰仁医疗,爱博诺德,伟思医疗,安必平,林华医疗,拱东医疗,天智航,三友医疗,赛科希德等。
截至 2020 年 1 月 31 日 24:00，国家卫生健康委员会公布全国确诊病例 11791 例，重症病例 1795 例。短期来看，预计疫情将继续持续一段时间。肺炎疫情期间，病毒检测带动试剂盒需求增加；病毒治疗带动医用设备及医用耗材需求增加。部分医疗器械企业有望构成业绩增厚。
As of 24:00 on January 31, 2020, the National Health Commission announced 11791 confirmed cases and 1795 severe cases. In the short term, the outbreak is expected to continue for some time. During the pneumonia epidemic, virus detection drives demand for kits; virus treatment drives demand for medical equipment and supplies. Some medical device companies are expected to increase their performance.
Driven by the rise of the younger generation of consumer groups and the development of new models in the medical beauty industry, the penetration rate and consumer demand of China's medical beauty industry continue to rise. In 2018, the penetration rate of Chinese medical users reached 7.4%, and women were the main medical and aesthetic consumers. The proportion is 88.9%. At present, there are more than 10,000 registered medical and beauty institutions in China, and the industry is in a period of rapid development. iiMedia Research found that embedding, double eyelids, and full body fat filling are the favorite surgical items for Chinese women and medical consumers, while nasal synthesis, tautological fat, cheeks, hair transplants, etc. For the Chinese male medical beauty consumer's favorite surgical project, potential customers in China's medical beauty industry are most concerned about the safety of surgery, followed by medical qualifications and word of mouth and surgery prices. Medical beauty as an emerging industry, public relations crisis, strict industry supervision, lack of relevant professionals is a factor that restricts its development, and in the future, with the influx of capital from the industry, the competition in China's medical and aesthetic industry will become more intense.
As the data of iiMedia Research showed, during the year of 2011 to 2017, the market scale of Chinese medical apparatus and instruments industry has increased at the speed of more than twice the world, but it still has a lot to do compared with the world. With the excellent economy, technology, policy and society environment, medical apparatus and instruments industry grows so well that many companies got financial investment; four Chinese companies ranked TOP 10 in a TOP 20 the most concerned medical apparatus and instruments companies ranking in the first half of 2018. Although the industry has an amount of development opportunities because of localization trend and industry upgrading, it is facing a series of problems, such as the decrease of trade surplus, the deficiency of R&D investment , the big amount of small companies and so on.
According to iiMedia Research data, the market size of China's physical examination industry will exceed 150 billion yuan in 2018. In terms of health care expenditure, in 2017, the per capita health care expenditure of urban residents in China has exceeded 1,800 yuan, and the per capita health care expenditure of rural residents has exceeded 1,000 yuan. With the improvement of national health management awareness, the number of physical examiners in China has increased year by year. In 2017, it has exceeded 500 million person-times. In the future, the increase in the types of health management services may become the key to the development of the physical examination industry.